1. Pfizer-identified small molecules target NS5A. dramatic phenotypic alterations in NS5A localization following treatment with NS5A inhibitors; NS5A was redistributed from the endoplasmic reticulum to lipid droplets. The NS5A relocalization did not occur in cells treated with other classes of HCV inhibitors, and NS5A-targeting molecules did not cause similar alterations in the localization of other … Continue reading 1
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed